eCARTv5 Clinical Deterioration Suite (eCART) vs Etiometry
AI Verdict
Choose eCARTv5 Clinical Deterioration Suite (eCART) if…
Choose eCARTv5 Clinical Deterioration Suite if your primary goal is to leverage an FDA-cleared, AI-powered early warning system that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients. This tool is ideal for hospitals seeking to integrate real-time risk stratification and embedded clinical pathways directly into their EHR system, aiming to minimize false alarms and reduce clinician workload while improving patient outcomes across various medical conditions.
View eCARTv5 Clinical Deterioration Suite (eCART) →Choose Etiometry if…
Choose Etiometry if your focus is on gaining deep physiologic insights and automating hospital-defined clinical pathways, particularly within high-acuity care settings like the ICU, OR, and ED. This platform is well-suited for organizations looking to aggregate and visualize real-time physiologic data from diverse sources, utilize FDA-cleared risk analytics (e.g., IDO2, IVCO2, ACD, HLA), and drive quality improvement initiatives through automated workflows and comprehensive clinical databases.
View Etiometry →When considering AI tools for high-acuity care, both AgileMD’s eCARTv5 Clinical Deterioration Suite and Etiometry offer robust solutions, each with distinct strengths. eCART excels at continuously assessing and predicting the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, integrating directly with EHRs to provide real-time risk stratification and embedded clinical pathways. Its core strength lies in its early warning system, designed to alert clinicians hours before critical illness, while minimizing false alarms. This makes eCART particularly well-suited for hospital medicine and critical care teams focused on proactive intervention and standardized care guidance across a broad patient population.
Etiometry, conversely, specializes in delivering deep physiologic insights and supporting the automation of hospital-defined clinical pathways, primarily in high-acuity settings like anesthesiology, critical care, and emergency medicine. Its key practical difference is its emphasis on comprehensive data aggregation and visualization from various sources, providing a holistic, vendor-neutral view of patient physiology. Etiometry’s FDA-cleared risk analytics, such as IDO2 and IVCO2, offer specific, data-driven insights for proactive and personalized care escalation or de-escalation. Physicians prioritizing a deep dive into real-time physiologic data and the automation of highly customized clinical pathways within specialized high-acuity environments may find Etiometry to be the more appropriate choice.
Ultimately, the decision hinges on the primary need: if the goal is a broad, continuous assessment of deterioration risk with integrated clinical pathways for general hospitalized adults, eCART is a strong contender. If the focus is on granular physiologic insights, comprehensive data aggregation, and the automation of specialized clinical pathways in high-acuity care, Etiometry offers a more tailored solution.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eCARTv5 Clinical Deterioration Suite (eCART) | Etiometry |
|---|---|---|
| Pricing | Contact vendor for tailored quote. | Contact for pricing |
| Deployment | Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems. | Hybrid (On-premise, Cloud-based) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EtiometryEtiometry has strong evidence of positive user experience, with 88% of nurses reporting that the platform makes their job easier and helps them complete tasks in fewer steps. It is also described as easy to use and helps streamline communication and charting. While AgileMD is praised for its intuitive interface and user-friendly design, specific metrics on user satisfaction are not as readily available.
Clinical Value
EtiometryBoth tools are FDA-cleared and aim to improve patient outcomes. Etiometry, however, has a broader range of FDA-cleared risk analytics (IDO2, IVCO2, ACD, HLA) and a more extensive evidence base with over 150 studies, demonstrating reductions in ICU length of stay, ventilation time, and readmissions. AgileMD's eCARTv5 has shown strong performance in predicting clinical deterioration and has undergone retrospective and prospective validation.
Pricing & Value
TieBoth companies state that pricing is available upon contacting the vendor for a tailored quote, indicating a lack of public pricing transparency. While Etiometry has published an economic impact analysis suggesting a significant ROI and annual savings for hospitals, AgileMD also highlights cost efficiency through reduced unnecessary tests and procedures. Without specific pricing details for either, it's difficult to definitively declare a winner in terms of overall value.
Enterprise Readiness
EtiometryBoth tools are HIPAA compliant and FDA cleared, indicating a strong foundation for enterprise use. Etiometry offers a hybrid deployment model (on-premise, cloud-based) which can be more flexible for large enterprises with varying IT infrastructures. Etiometry also has 10 FDA clearances and is used in over 175 ICUs across more than 50 hospitals, demonstrating widespread adoption and scalability. AgileMD is cloud-based SaaS and integrates directly with EHRs, with over 400 hospitals and 150,000 clinical users.
Innovation
EtiometryBoth tools leverage AI for clinical decision support. Etiometry stands out with its development of multiple FDA-cleared, model-based risk algorithms for various physiological insights, including non-invasive prediction of carbon dioxide retention in neonates. Etiometry also has a cardiogenic shock tool that supports institution-defined classification within clinical pathways. AgileMD's eCARTv5 utilizes a gradient-boosted machine-learning model for early warning, which is also innovative.
Support & Docs
TieBoth companies encourage direct contact for support and provide resources like documentation and training. Etiometry's implementation process has been described as straightforward with responsive support, and minimal ongoing IT workload. AgileMD also offers various training resources and support channels including email, phone, chat, and a knowledge base. Without more detailed comparative information on the breadth and depth of their documentation and support services, it's a tie.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eCARTv5 Clinical Deterioration Suite (eCART) | Etiometry |
|---|---|---|
| Name | eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d) | Etiometry |
| Company | AgileMD | Etiometry |
| Tagline | AI-powered clinical decision support for better healthcare outcomes and efficiency. | Clinical Intelligence for High-Acuity Care Teams |
| Description | AgileMD's eCARTv5 Clinical Deterioration Suite is an FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. | Etiometryu2019s platform delivers deep physiologic insights and supports the automation of hospital defined clinical pathwaysu2014enabling clinicians to make timely decisions and actions that may improve outcomes, reduce costs, and ease the burden on care teams. |
| Key Features | AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities | Data Aggregation & Visualization (Holistic view, vendor-neutral); FDA-Cleared Risk Analytics (IDO2, IVCO2, ACD, HLA); Clinical Pathway Automation; Quality Improvement Application/Clinical Database; AI-driven clinical intelligence; Real-time physiologic data aggregation; Early deterioration identification; Proactive & personalized care escalation/de-escalation |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine | Anesthesiology, Critical Care, Emergency Medicine |
Videos
Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Etiometry.
Frequently Asked Questions
More Comparisons
More matchups featuring eCARTv5 Clinical Deterioration Suite (eCART) or Etiometry
- eCARTv5 Clinical Deterioration Suite (eCART) vs EvidenceMD
- eCARTv5 Clinical Deterioration Suite (eCART) vs Elsevier
- eCARTv5 Clinical Deterioration Suite (eCART) vs Clair - The AI Clinical Reference Tool
- eCARTv5 Clinical Deterioration Suite (eCART) vs Google Cloud AI (with BAA)
- eCARTv5 Clinical Deterioration Suite (eCART) vs Microsoft Azure AI (with BAA)
- eCARTv5 Clinical Deterioration Suite (eCART) vs Lumiata AI